home
•
contacts
•
sitemap
•
japan
•
search
About
Company Overview
History
Management Team
Board of Directors
Locations
Careers
Pipeline
BTG Pipeline
Partnered Programmes
Marketed Products
Business Development
Our Focus
Partnering Opportunities
Contacts
Investors
Share Price Data
Stock Exchange Announcements
Press Releases
Financial Reports & Accounts
Financial Results
Presentations
BTG Share Dealing Facility
Email Alerts
Financial Calendar
Corporate Governance
Corporate Social Responsibility
Investor Contacts
News
Press Releases
Stock Exchange Announcements
Events
Publications
Email Alerts
Media Contact
Pipeline
BTG Pipeline
Varisolve
®
BGC20-0582
BGC20-0166
BGC20-1259
BGC20-1531
BGC20-0134
Partnered Programmes
Campath
®
CB7630 (abiraterone)
TRX4
Misopess™
ABIO-0801
Juvidex™
Modafinil Combination
ONX 0801
β-Amyloid Inhibitors
Marketed Products
Pipeline
>
Partnered Programmes
>
ABIO-0801
ABIO-0801
Product
ABIO-0801
Licensee
Abiogen Pharma
Indication
Anxiety
Phase
Phase II
Description
Treatment for anxiety.
Return to Pipeline
© BTG International Ltd 2008 •
Legal Notice
•
Accessibility
Product